Literature DB >> 8454483

External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas.

L L Gunderson1, D M Nagorney, D C McIlrath, J M Fieck, H S Wieand, A Martinez, D J Pritchard, F Sim, J A Martenson, J H Edmonson.   

Abstract

PURPOSE: Intraoperative irradiation with electrons was used in conjunction with external beam irradiation and maximal surgical resection in 20 patients with locally advanced soft tissue sarcomas or desmoids. This manuscript presents results with regard to tolerance of treatment and its impact on tumor control and survival. METHODS AND MATERIALS: Ten patients presented with previously untreated primary sarcomas and 10 at the time of local recurrence (two had recurrent desmoid tumors). Tumor location was retroperitoneal in 19 and in the low anterior neck in one. A partial or gross total resection was performed prior to the external beam or intraoperative component of irradiation in every patient, but all had positive resection margins. Patients received 4500-6000 cGy of fractionated, external beam irradiation and an IORT dose of 1000-2000 cGy. Chemotherapy was given only at the time of disease progression.
RESULTS: Fourteen of 20 patients (70%) were alive; 11 (55%) were free of disease (4/10 primary, 7/10 recurrent), but 1 required hemipelvectomy for salvage. Progression within the intraoperative irradiation field was documented in only 1 patient (5%) and within the external beam field in 3/20 (15%). Blood born distant metastasis occurred in 5 patients (25%) and peritoneal seeding in 1 (5%). The distant failure incidence by grade was 1/8 (13%) for Grades 1, 2 and 5/12 (42%) for Grades 3, 4. Only 1 patient (5%) developed a > or = severe neuropathy, and small bowel obstruction requiring exploration also occurred in a single patient.
CONCLUSION: In view of acceptable tolerance and the high current rate of local tumor control, in spite of incomplete surgical resections, further evaluation of intraoperative irradiation as a component of treatment is indicated for locally advanced primary and recurrent soft tissue sarcomas.

Entities:  

Mesh:

Year:  1993        PMID: 8454483     DOI: 10.1016/0360-3016(93)90011-j

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Intraoperative radiotherapy for extremity soft-tissue sarcomas: can long-term local control be achieved?

Authors:  Esther Carbó-Laso; Pablo Sanz-Ruiz; José Antonio Calvo-Haro; Miguel Cuervo-Dehesa; Rubén Pérez-Mañanes; Lydia Mediavilla-Santos; Coral Sánchez-Pérez; Ana Álvarez-González; Javier Vaquero-Martín
Journal:  Int J Clin Oncol       Date:  2017-07-17       Impact factor: 3.402

2.  Postoperative radiotherapy for locally advanced colon cancer.

Authors:  N A Janjan
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

3.  The enigma of desmoid tumors.

Authors:  J J Lewis; P J Boland; D H Leung; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

4.  Clinical outcomes of intraoperative radiation therapy for extremity sarcomas.

Authors:  Quy N H Tran; Anne C Kim; Alexander R Gottschalk; William M Wara; Theodore L Phillips; Richard J O'donnell; Vivian Weinberg; Daphne A Haas-Kogan
Journal:  Sarcoma       Date:  2006

5.  Carbon Ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheaths tumors: acute toxicity and preliminary outcome.

Authors:  Alexandra D Jensen; Matthias Uhl; Naved Chaudhri; Klaus K Herfarth; Juergen Debus; Falk Roeder
Journal:  Radiat Oncol       Date:  2015-05-06       Impact factor: 3.481

6.  Intraoperative radiotherapy using a mobile electron LINAC: a retroperitoneal sarcoma case.

Authors:  A Sam Beddar; Sunil Krishnan
Journal:  J Appl Clin Med Phys       Date:  2005-08-12       Impact factor: 2.102

7.  Management of advanced adult soft tissue sarcoma.

Authors:  Vivien H C Bramwell
Journal:  Sarcoma       Date:  2003

8.  Current perspectives on desmoid tumors: the mayo clinic approach.

Authors:  Siddharth B Joglekar; Peter S Rose; Franklin Sim; Scott Okuno; Ivy Petersen
Journal:  Cancers (Basel)       Date:  2011-08-08       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.